LIPO
LIPELLA PHARMACEUTICALS INC.
NASDAQ · Healthcare · Biotechnology · US
$0.00
+0.00%Next report
Analyst consensus
- Next report date
- Dec 2, 2026
- EPS estimate
- -$1.28
- Revenue estimate
- $146.0K
Latest reported
- Last report date
- Nov 14, 2025
- EPS actual
- -$0.28
- EPS estimate
- —
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +5.6%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Nov 14, 2025 | — | -$0.28 | — | — |
| Aug 14, 2025 | — | -$0.31 | — | $86.7M |
| May 14, 2025 | — | -$0.64 | — | $129.4M |
| Mar 27, 2025 | -$2.43 | -$1.19 | Beat 51.03% | $173.7K |
| Nov 14, 2024 | -$0.96 | -$1.29 | Miss -34.38% | $80.4K |
| May 9, 2024 | -$1.28 | -$1.28 | In line | $146.0K |
| Feb 27, 2024 | — | -$0.72 | — | $120.8K |
| Nov 13, 2023 | — | -$1.84 | — | $104.1M |
| Aug 14, 2023 | — | -$2.16 | — | $106.7M |
| Jun 30, 2023 | — | -$1.49 | — | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 2, 2026